Daniel E. Wolf, P.C.

Daniel Wolf's representative experience includes advising:

Mergers & Acquisitions

• Bristol Myers Squibb in its $90 billion acquisition of Celgene and related $13.4 billion divesture of Celgene's OTEZLA® program to Amgen
• Danaher Corporation in its $21 billion acquisition of GE's Biopharma business and $4 billion acquisition of Cepheid
• Oak Street Health in its $10.6 billion sale to CVS Health
• Swift Transportation in its $6 billion stock-for-stock merger with Knight Transportation
• Cvent in its $4.6 billion sale to Blackstone

Cross-Border Transactions

• Teva Pharmaceutical in its $40.5 billion acquisition of Allergan Generics and U.S. antitrust clearance
• Grubhub in its $7.3 billion sale to Just Eat Takeaway.com
• Mead Johnson Nutrition in its $18 billion sale to Reckitt Benckiser plc
• NortonLifeLock in its ~$25 billion combination with Avast

Contested Situations

• Wyndham Hotels & Resorts in its successful defense of a $7.8 billion hostile takeover by Choice Hotels International
• Akzo Nobel in its successful defense of an unsolicited $28 billion takeover attempt by PPG Industries
• HanesBrands in connection with its cooperation agreement with Barington
• Clear Channel Outdoor in its cooperation agreement with Legion Partners

Private Equity Sponsor Transactions

• Vista Equity Partners in its $16.5 billion acquisition of Citrix Systems
• Stone Point Capital in its $6 billion acquisition of CoreLogic
• CC Capital in its $6.9 billion acquisition of Dun & Bradstreet
• Hellman & Friedman in its $10.2 billion acquisition of Zendesk